Keywords: cell, genesys, cg7870, starts, combi, trial, biotechnology

Cell Genesys' CG7870 starts combi trial

Article | 23 August 2004

Print This

US biotechnology firm Cell Genesys has initiated a new Phase I/II trialof its CG7870, an oncolytic virus therapy for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in